Roche-HIV.com
 
  Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide | Contact webmaster  
  
   Search this site
  Roche in HIV
  Understanding HIV
 
  About HIV
 
  Management issues
 
  Guidelines (HIV and HCV)
  Pharmaceutical products  
  Commitment to research  
  Commitment to access  
  Conferences  
  News and features
  Healthcare professionals
Last updated on : 21-Jul-05
Management guidelines

Guidelines for the management of HIV and hepatitis C virus (HCV) infection have been developed in order to establish a consensus among experts and, more importantly, to make this available to those involved in clinical practice.

It is never the role of guidelines to provide a substitute for the clinical judgment of individual physicians, or to predetermine the needs of individual patients. This is especially true in the case of guidelines relating to HIV and HCV, management of which is typically highly individualized.

Nevertheless, as a distillation of experience, expertise and detailed discussion, guidelines can provide an invaluable practical resource.

Notable among the guidelines for HIV and HCV management are the following:

 

 

DHHS Guidelines: DHHS Guidelines:
 

Guidelines from the Panel on Clinical Practices for Treatment of HIV Infection, first convened by the US Department of Health and Human Services (DHHS) and the Henry J Kaiser Family Foundation in 1996, are regularly updated to constitute so-called living documents

 
The British HIV Association Guidelines:
 
The BHIVA Treatment Guidelines for 2005 are prepared by a writing sub-committee, who jointly take responsibility for the recommendations, which are based on published data and evidence-based medicine.
 

The BHIVA Guidelines are updated to reflect the latest findings and are subject to scrutiny by a lengthy consultative procedure which encourages comments from our membership, community organisations, pharmaceutical companies and others.

 
 
 
The HIV�HCV International Panel Recommendations:

 
In 2002, an international panel of experts met to discuss research and practice protocols related to the treatment of HIV and hepatitis C virus (HCV) co-infection. The recommendations that were formulated by this panel provide a consensus regarding general treatment strategy in patients with HIV�HCV co-infection.
 
 
 
Consensus conference on chronic viral hepatitis and HIV infection
(updated Spanish recommendations):

 
A Spanish panel of experts convened in 2002 to discuss the management of chronic viral hepatitis in the setting of HIV infection. The resultant recommendations, which were scored according to the Infectious Disease Society of America (IDSA) grading system, represent a comprehensive overview of the management of hepatitis B and C in HIV-infected individuals.
 
 

 

 

 

 

 

 

 

 

Home | Disclaimer | Sitemap | Glossary | Library cart | Useful links | Keep me informed | Roche worldwide
All information contained in this website is generated and maintained by F. Hoffmann-La Roche, Ltd, Basel, Switzerland. This site is intended for use by physicians only. This site is not intended for residents of the United States of America.
Copyright 2006 F. Hoffmann La Roche Ltd.
Contact webmaster